According to Yu et al. DHT reinforces hepatocellular carcinoma cell division depending on AR activation [123], and the decline in HCC malignancy after AR antagonism treatment is linked with a decrease in blood DHT [124]. This evidence concerns the gene AR and hepatocellular carcinoma.